ASX listed digital health company ResApp has signed a memorandum of understanding with health products manufacturer RB, formerly known as Reckitt Benckiser, to develop a smartphone app for consumers that uses ResApp’s cough-based algorithms to identify different respiratory conditions.

ResApp and RB have agreed to work together to build and test a prototype app for consumers to self-assess, or assess with the assistance of a pharmacist, their respiratory symptoms.